FANCL saw the highest growth of 132% in patent filings in February and 599% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 85% and grants by 599%. GlobalData’s DataBook provides a comprehensive analysis of FANCL’s patent filings and grants. Buy the databook here.
FANCL has been focused on protecting inventions in Japan(JP) with 25 publications in Q1 2024
The Japan(JP) Patent Office dominates the patent filings and grants with nearly 100% filings and 86% grants. The Japan(JP), and Taiwan(TW) patent Office are among the top ten patent offices where FANCL is filings its patents. Among the top granted patent authorities, FANCL has 86% of its grants in Japan(JP) and 14% in Taiwan(TW).
F. Hoffmann-La Roche could be the strongest competitor for FANCL
Patents related to health & wellness and meat & seafood alternatives lead FANCL's portfolio
FANCL has the highest number of patents in health & wellness followed by, meat & seafood alternatives and rare diseases. For health & wellness, nearly 33% of patents were filed and no patents were granted in Q1 2024.
Cosmetics & toiletries related patents lead FANCL portfolio followed by skincare, and suncare
FANCL has highest number of patents in cosmetics & toiletries followed by skincare, suncare, anti-agers, and food. For cosmetics & toiletries, nearly 31% of patents were filed and 36% of patents were granted in Q1 2024.
For comprehensive analysis of FANCL's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.